Table 4.

Changes in clinical parameters in the subgroups according to the treatments.

Variables	Placebo (n = 41)	BC (n = 45)	p-value
ITT
Weight (Kg)	−2.7 ± 2	−4.2 ± 3	0.004
CAP score (dB/m)	−26.9 ± 43	−48.2 ± 39	0.020
CAP (%)	−9.2 ± 16	−15.9 ± 13	0.036
Improvement (%)	51	76	0.025
On-Treatment
Weight (Kg)	−2.7 ± 2	−4.4 ± 3	0.002
CAP score (dB/m)	−25.7 ± 45	−51.7 ± 38	0.007
CAP (%)	−8.7 ± 17	−17.1 ± 12	0.013
Improvement (%)	50	79	0.010
Women
Weight (Kg)	−2.6 ± 2	−4.3 ± 3	0.063
CAP score (dB/m)	−22.3 ± 47	−54.1 ± 35	0.034
CAP (%)	−8 ± 18	−17.8 ± 10	0.067
Improvement (%)	56	83	0.13
Men
Weight (Kg)	−2.8 ± 2	−4.2 ± 3	0.030
CAP score (dB/m)	−29.9 ± 42	−44.3 ± 42	0.225
CAP (%)	−9.9 ± 15	−14.7 ± 14	0.249
Improvement (%)	48	70	0.15
Age ≤ 50 years
Weight (Kg)	−2.9 ± 2	−4.1 ± 3	0.17
CAP score (dB/m)	−43.4 ± 37	−39.5 ± 43	0.75
CAP (%)	−15.7 ± 13	−13.9 ± 15	0.67
Improvement (%)	67	73	0.74
Age > 50 years
Weight (Kg)	−2.4 ± 2	−4.4 ± 2	0.004
CAP score (dB/m)	−9.7 ± 44	−56.5 ± 34	<0.001
aCAP score (dB/m)*	−13.7 ± 9	−52.9 ± 8	0.004
CAP (%)	−2.3 ± 16	−17.9 ± 10	0.001
Improvement (%)	35	78	0.006
Android Obesity
Weight (Kg)	−2.8 ± 3	−4.4 ± 3	0.016
CAP score (dB/m)	−23.7 ± 45	−51.2 ± 39	0.014
CAP (%)	−8.1 ± 17	−16.8 ± 13	0.027
Improvement (%)	44	80	0.007
Gynoid Obesity
Weight (Kg)	−2.5 ± 3	−3.8 ± 3	0.22
CAP score (dB/m)	−33.3 ± 41	−37.6 ± 41	0.80
CAP (%)	−11.4 ± 16	−12.9 ± 14	0.80
Improvement (%)	64	60	1
Metabolic Syndrome
Weight (Kg)	−2.8 ± 2	−3.4 ± 2	0.43
CAP score (dB/m)	−9.1 ± 54	−47 ± 54	0.13
CAP (%)	−2.3 ± 20	−14.2 ± 16	0.16
Improvement (%)	55	45	0.65
Overweight & Obesity
Weight (Kg)	−3.0 ± 2	−4.5 ± 3	0.005
CAP score (dB/m)	−25.6 ± 46	−50.7 ± 40	0.018
CAP (%)	−8.4 ± 17	−16.5 ± 18	0.031
Improvement (%)	44	78	0.007

CAP, controlled attenuation parameter.

^*CAP score adjusted for body weight change.